On April 6 , the City of Rockford   the makers of H. P. Acthar , " to challenge an    unfair and deceptive scheme " that the company undertook " to enhance and maintain Mallinckrodt ’s monopoly power in the U. S. market for adrenocorticotropic hormone ( ACTH ) drugs in violation of the U. S. antitrust laws ." ’ "   suits contesting high prices have become increasingly common ; one   and another   have been filed in the past few months .In 2016 , Providence , Rhode Island , sued generic drugmakers over the antibiotic doxycycline and a heart medication called digoxin .The antibiotic has since generic drugmakers in a    case brought by 20 state attorneys general .